The New IMS World Review Country Profile on South Korea is Available Now

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c88777) has announced the
addition of "IMS World Review Country Profile - South Korea" to their
offering.

The profile analyzes the critical components that make up a
pharmaceutical company, providing you with a clear assessment of the
relative strengths and weaknesses of a company's business strategy.
Sales performance is analysed in terms of geographic region, major
corporations, therapeutic classes, major products and new product
activity.

All data is available over a 5 year period for easy trend analysis
and is based on Quarter 4 sales figures.

Topics Covered:

Data Values and Definitions

Channels of Distribution

Audited Market Trend

Leading Companies - Top 35

Leading Corporations - Top 35

Fastest Growing Companies

Market Share By Corporate Nationality

15 Largest Therapeutic Classes

15 Fastest-Growing 3rd And 4th Level Therapeutic Classes

Therapeutic Class Profile

Leading Products - Top 40

Leading New Products - Top 40

Forms Most Commonly Used - Top 15

Companies Mentioned:

-- Dong A

-- Pfizer Korea

-- Sanofi-Aventis Kor

-- Glaxosmithkline

-- Dae Woong

-- Han Mi

-- Yuhan Co.

-- Choong Wae

-- Novartis Korea Ltd

-- Il Dong

-- Msd Korea

-- Cj Corp.

-- Chong Kun Dang

-- Korea Green Cross

-- Handok

-- Astrazeneca Korea

-- Janssen Korea

-- Bo Ryung

-- Je Il Ph.

-- Roche Korea Co.Ltd

-- Bukwang

-- Dong Wha

-- Lilly Korea Ltd.

-- Sk Chemicals

-- Bayer Korea

-- Sam Jin

-- Shin Poong

-- Lg Life Sciences

-- Hyundai Ph.

-- B.Ingelheim Korea

-- Astellas Pharma Kr

-- Pacific Ph

-- Samil Ph.

-- Kukje Ph.

-- Schering Korea

For more information, visit
here

Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com

Copyright Business Wire 2008